Works matching IS 03065251 AND DT 2006 AND VI 61 AND IP 3

Results: 20

Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.

Published in:: British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 361, doi. 10.1111/j.1365-2125.2005.02551.x
Publication type:: Article

Clinically relevant drug interactions with antiepileptic drugs.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 246, doi. 10.1111/j.1365-2125.2005.02529.x

By:

Perucca, Emilio

Publication type:

Article

Pharmacokinetics of a new testosterone transdermal delivery system, TDS<sup>®</sup>-testosterone in healthy males.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 275, doi. 10.1111/j.1365-2125.2005.02542.x

By:

Chik, Z.;
Johnston, A.;
Tucker, A. T.;
Chew, S. L.;
Michaels, L.;
Alam, C. A. S.

Publication type:

Article

Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 301, doi. 10.1111/j.1365-2125.2005.02545.x

By:

Seok Hwee Koo;
Woon Fei Ho;
Edmund Jon Deoon Lee

Publication type:

Article

Author's Reply: Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.

Published in:

2006

By:

Furuta, Takahisa;
Shirai, Naohito;
Sugimoto, Mitsushige;
Nakamura, Akiko;
Hishida, Akira

Publication type:

Letter

Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 289, doi. 10.1111/j.1365-2125.2005.02567.x

By:

Simpson, Julie A.;
Hughes, Dyfrig;
Manyando, Christine;
Bojang, Kalifa;
Aarons, Leon;
Winstanley, Peter;
Edwards, Geoffrey;
Watkins, William A.;
Ward, Steve

Publication type:

Article

Disposition and pharmacodynamics of propofol during isovolaemic haemorrhage followed by crystalloid resuscitation in humans.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 256, doi. 10.1111/j.1365-2125.2005.02555.x

By:

Takizawa, Eri;
Takizawa, Daisuke;
Hiraoka, Haruhiko;
Saito, Shigeru;
Goto, Fumio

Publication type:

Article

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 309, doi. 10.1111/j.1365-2125.2005.02556.x

By:

Uno, Tsukasa;
Shimizu, Mikiko;
Yasui-Furukori, Norio;
Sugawara, Kazunobu;
Tateishi, Tomonori

Publication type:

Article

ASCOT – old or new drugs for blood pressure?

Published in:

2006

By:

Ritter, James;
Warren, John

Publication type:

Letter

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 315, doi. 10.1111/j.1365-2125.2005.02566.x

By:

Miura, Masatomo;
Kagaya, Hideaki;
Tada, Hitoshi;
Uno, Tsukasa;
Yasui-Furukori, Norio;
Tateishi, Tomonori;
Suzuki, Toshio

Publication type:

Article

Tadalafil pharmacokinetics in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 280, doi. 10.1111/j.1365-2125.2005.02553.x

By:

Forgue, S. Thomas;
Patterson, Beverley E.;
Bedding, Alun W.;
Payne, Christopher D.;
Phillips, Diane L.;
Wrishko, Rebecca E.;
Mitchell, Malcolm I.

Publication type:

Article

Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 262, doi. 10.1111/j.1365-2125.2005.02568.x

By:

Resch, Ulrike;
Tatzber, Franz;
Budinsky, Alexandra;
Sinzinger, Helmut

Publication type:

Article

Initial phase of chronic medication use; patients’ reasons for discontinuation.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 352, doi. 10.1111/j.1365-2125.2005.02569.x

By:

Hugtenburg, J. G.;
Blom, A. Th. G.;
Kisoensingh, S. U.

Publication type:

Article

The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 321, doi. 10.1111/j.1365-2125.2005.02570.x

By:

Davies, Benjamin J.;
Coller, Janet K.;
James, Heather M.;
Somogyi, Andrew A.;
Horowitz, John D.;
Sallustio, Benedetta C.

Publication type:

Article

Rare diseases and orphan drugs.

Published in:

2006

By:

Aronson, J. K.

Publication type:

Editorial

Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 336, doi. 10.1111/j.1365-2125.2005.02572.x

By:

Todros, T.;
Verdiglione, P.;
Oggé, G.;
Paladini, D.;
Vergani, P.;
Cardaropoli, S.

Publication type:

Article

Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 326, doi. 10.1111/j.1365-2125.2005.02573.x

By:

Morrish, Glynn A.;
Foster, David J. R.;
Somogyi, Andrew A.

Publication type:

Article

When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 341, doi. 10.1111/j.1365-2125.2006.02577.x

By:

Kahan, Natan R.;
Chinitz, David P.;
Waitman, Dan-Andrei;
Kahan, Ernesto

Publication type:

Article

Orphan drug development is progressing too slowly.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 355, doi. 10.1111/j.1365-2125.2006.02579.x

By:

Joppi, Roberta;
Bertele, Vittorio;
Garattini, Silvio

Publication type:

Article

Curriculum development in pharmacotherapy: testing the ability of preclinical medical students to learn therapeutic problem solving in a randomized controlled trial.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 345, doi. 10.1111/j.1365-2125.2005.02571.x

By:

Vollebregt, J. A.;
Metz, J. C. M.;
de Haan, M.;
Richir, M. C.;
Hugtenburg, J. G.;
de Vries, T. P. G. M.

Publication type:

Article